Hepatitis C is a chronic liver condition affecting millions of Americans, and the infection occurs through transmission with infected needles or infected blood. Although treatment regimens have been available for some time, they have been limited by the need for injectible medication and limitations in response.
A new combination of oral medications, avoiding injections and providing superior results and tolerability has just been described in the New England Journal of Medicine. Although there are concerns about price, there is no doubt this regimen combining 2 or 3 different oral medications is going to make treatment of Hepatitis C more readily available and effective.